BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33083033)

  • 1. Humoral Immune Memory to Hepatitis B Vaccine after Primary Vaccination of Children and Adolescents in Assiut, Egypt.
    Salama II; Sami SM; Elserougy SM; Emam HM; Salama SI; Elhariri HM; Hemeda SA; Hassanain AI; Abdel Mohsen AM; Fouad WA; El Etreby LA; Said ZN
    Oman Med J; 2020 Sep; 35(5):e175. PubMed ID: 33083033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of compulsory and booster doses of hepatitis B vaccine among children in Cairo, Egypt.
    Salama I; Sami S; Saleh R; Mohsen A; Elserougy S; Emam H; Said Z
    J Egypt Public Health Assoc; 2017 Jun; 92(2):77-85. PubMed ID: 30184404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early and long term anamnestic response to HBV booster dose among fully vaccinated Egyptian children during infancy.
    Salama II; Sami SM; Said ZN; Salama SI; Rabah TM; Abdel-Latif GA; Elmosalami DM; Saleh RM; Abdel Mohsin AM; Metwally AM; Hassanin AI; Emam HM; Hemida SA; Elserougy SM; Shaaban FA; Fouad WA; Mohsen A; El-Sayed MH
    Vaccine; 2018 Apr; 36(15):2005-2011. PubMed ID: 29530634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
    Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
    Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
    Su FH; Bai CH; Chu FY; Lin YS; Su CT; Yeh CC
    Vaccine; 2012 Jun; 30(27):4034-9. PubMed ID: 22531558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Are teenagers immunized in infancy still protected against hepatitis B?].
    Pokorska-Lis M; Marczyńska M
    Przegl Lek; 2010; 67(1):13-7. PubMed ID: 20509565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
    Moses J; Alkhouri N; Shannon A; Raig K; Lopez R; Danziger-Isakov L; Feldstein AE; Zein NN; Wyllie R; Carter-Kent C
    Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response to second vaccination series of hepatitis B virus among booster dose non-responders.
    Salama II; Sami SM; Salama SI; Rabah TM; El Etreby LA; Abdel Hamid AT; Elmosalami D; El Hariri H; Said ZN
    Vaccine; 2016 Apr; 34(16):1904-8. PubMed ID: 26930367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
    Jafarzadeh A; Montazerifar SJ
    J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of protective anti-HBs antibody levels and anamnestic response to HBV booster vaccination: A cross-sectional study among healthcare students 20 years following the universal immunization campaign in Italy.
    Dini G; Toletone A; Barberis I; Debarbieri N; Massa E; Paganino C; Bersi F; Montecucco A; Alicino C; Durando P
    Hum Vaccin Immunother; 2017 Feb; 13(2):440-444. PubMed ID: 27925503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B Seroprotection and the Response to a Challenging Dose among Vaccinated Children in Red Sea Governorate.
    Sami SM; Salama II; Abdel-Latif GA; El Etreby LA; Metwally AI; Abd El Haliem NF
    Open Access Maced J Med Sci; 2016 Jun; 4(2):219-25. PubMed ID: 27335590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study.
    Chang YC; Wang JH; Chen YS; Lin JS; Cheng CF; Chu CH
    BMC Public Health; 2014 Sep; 14():991. PubMed ID: 25248369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
    Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
    Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of HBV Vaccine's Protection and Response to Hepatitis B Booster Immunization in 5- to 7-Year-Old Children in the Kohgiloyeh and Boyerahmad Province, Iran.
    Yazdanpanah B; Safari M; Yazdanpanah S
    Hepat Mon; 2010; 10(1):17-21. PubMed ID: 22308120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults.
    Wang Y; Chen T; Lu LL; Wang M; Wang D; Yao H; Fan C; Qi J; Zhang Y; Qu C
    Vaccine; 2017 Feb; 35(7):1064-1070. PubMed ID: 28069363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
    Zhu CL; Liu P; Chen T; Ni Z; Lu LL; Huang F; Lu J; Sun Z; Qu C
    Vaccine; 2011 Oct; 29(44):7835-41. PubMed ID: 21816197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and reactogenicity of a recombinant hepatitis B vaccine in subjects over age of forty years and response of a booster dose among nonresponders.
    Das K; Gupta RK; Kumar V; Kar P
    World J Gastroenterol; 2003 May; 9(5):1132-4. PubMed ID: 12717874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of antibody persistence after a four-dose primary hepatitis B vaccination and anamnestic immune response in children under 6 years.
    Tfifha M; Kacem S; Ben Rejeb M; Naija S; Boujaafar N; Abroug S; Trabelsi A
    J Med Microbiol; 2019 Nov; 68(11):1686-1693. PubMed ID: 31592765
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictors of Booster Response to Hepatitis B Vaccine at 15 years of age: A Cross-Sectional School-Based Study.
    Chen YS; Chu CH; Wang JH; Lin JS; Chang YC
    Pediatr Neonatol; 2016 Aug; 57(4):302-9. PubMed ID: 26750404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.